|
May 23
|
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
|
|
Mar 13
|
Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential
|
|
Mar 2
|
Why Tiziana Life Sciences Ltd (TLSA) is Skyrocketing So Far in 2025
|
|
Feb 27
|
Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury
|
|
Feb 25
|
Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter
|
|
Feb 21
|
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
|
|
Feb 18
|
Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program
|
|
Feb 12
|
3 Promising US Penny Stocks With Market Caps Over $20M
|
|
Feb 11
|
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
|
|
Sep 19
|
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
|
|
Aug 19
|
Tiziana Life Sciences Appoints New Chief Executive Officer
|
|
Aug 14
|
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
|
|
Jul 24
|
Tiziana Life Sciences Granted FDA Fast Track Designation
|
|
Jun 28
|
Tiziana Receives $3.4 Million in Non-Dilutive Funding
|
|
Jun 26
|
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
|
|
Jun 11
|
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
|
|
May 13
|
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
|
|
Apr 25
|
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
|
|
Apr 23
|
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
|
|
Apr 22
|
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access Program
|